Previous Close | 4.0500 |
Open | 3.9500 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 3.9500 - 4.3500 |
52 Week Range | 2.1900 - 7.9000 |
Volume | |
Avg. Volume | 631,695 |
Market Cap | 3.113B |
Beta (5Y Monthly) | 1.68 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.5400 |
Earnings Date | Nov 06, 2023 - Nov 10, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.32 |
Subscribe to Yahoo Finance Plus to view Fair Value for CURLF
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
With cannabis usage continuing to rise, now could be an opportune time to invest in marijuana stocks. Over 52 million Americans currently use cannabis, and legalization seems inevitable as more states approve recreational and medical use. However, investing in cannabis stocks is extremely risky and highly speculative. I’d recommend taking only a small position in most names, as the regulatory environment remains uncertain. Though public opinion has shifted, full federal legalization in the U.S.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the launch of Zero Proof, a new brand of THC drinkables in fast-acting, sessionable and easy-to-use formats. The brand's inaugural product offering, Squeeze, is now available at all Curaleaf locations in Illinois and will be followed by additional SKUs in the coming months.